Restoring cortical disinhibition improves Huntington’s disease phenotypes
Animals All animal procedures were performed in accordance with guidelines set forth and protocols approved by the UCSD…
Teva’s Data on AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Highlight Long-Term Advances in Tardive Dyskinesia Treatment and Care
Teva Pharmaceutical Industries Ltd New analysis from the IMPACT-TD Registry demonstrates that treatment with AUSTEDO and AUSTEDO XR led…
uniQure Provides FDA Update on AMT-130; BLA Timing Unclear
uniQure (NASDAQ: QURE) on Nov. 3, 2025 announced FDA feedback…
New gene therapy for Huntington’s ‘changes everything’, say researchers
UK researchers say they have slowed the progression of the fatal neural condition Huntington’s disease for the first…